Contributes reviews on supplier material. Based in Rosario.
member · joined 15 Jun 2025
Overview — page 2 of 5
comment on formulary is the most under-discussed thing in c/coldchain in c/insurancefights · 54 points · 3 months ago
Denied for prior auth, resubmitted with external review documentation, approved on appeal. The criteria exist, you just have to meet them.
Long-ish post, sorry. tl;dr at the bottom. I have been tracking COA against eGFR for 33 weeks because I could not find anyone who had. The correlation is weaker than I…
comment on why does nobody talk about testing in c/vendorvetting · 333 points · 4 months ago
No. This is the kind of confident post that gets copied into a screenshot and repeated for years. Where is the evidence.
comment on anyone else notice endpoint kicking in around week 19 in c/trialwatch · 35 points · 4 months ago
Disagree but this is the good kind of wrong — it is specific enough to be checked.
comment on small win: batch stopped being a problem at week 6 in c/coa · 14 points · 4 months ago
Not to be pedantic but batch and certificate of analysis are being used interchangeably and they are not interchangeable in real life.
comment on the step therapy question that gets asked weekly, answered properly in c/insurancefights · 9 points · 5 months ago
Did you get step therapy or outright denial?
comment on [Meta] the STEP rule is doing its job and people should stop complaining in c/trialwatch · 16 points · 5 months ago
the relative risk reduction in headlines is not the whole story
comment on am I the only one who found area percent harder than the injections in c/coa · 503 points · 5 months ago
area% is not mass%, and here is exactly why it matters
comment on genuine question about hazard ratio that I am slightly embarrassed to ask in c/trialwatch · 1 points · 6 months ago
Which trial and what was the primary endpoint?
comment on help me understand MASH, I have read the wiki twice in c/survodutide · 1 points · 6 months ago
This is correct. Do not generalise from tirzepatide.
comment on tried sequence for 20 weeks. here is what happened. in c/bpc157 · 44 points · 7 months ago
How many weeks between the two measurements?
comment on anyone else notice water content kicking in around week 39 in c/coa · 41 points · 7 months ago
redact your own name, not the vendor's batch details
comment on anyone else notice water content kicking in around week 39 in c/coa · 69 points · 7 months ago
PDF metadata is checkable in fifteen seconds
comment on tried sequence for 20 weeks. here is what happened. in c/bpc157 · -8 points · 7 months ago
Did anything else change in the same window?
comment on anyone else notice water content kicking in around week 39 in c/coa · 0 points · 7 months ago
purity and net content are two different numbers, same vial
comment on anyone else notice water content kicking in around week 39 in c/coa · 1 points · 7 months ago
What is the method line say? Not the technique, the actual method.
I have had 20 orders now and I keep a table, so here is the honest summary rather than a vibe. Material has been consistent. Communication has not. Shipping has varied…
comment on my TSH moved and I cannot work out whether area percent is why in c/coa · 29 points · 7 months ago
the counterion is part of the mass you paid for
comment on the denial question that gets asked weekly, answered properly in c/insurancefights · 66 points · 7 months ago
Strongly agree. Step therapy is predictable if you have the criteria.
comment on dual agonist — my 21-week log, condensed into one table in c/survodutide · 17 points · 7 months ago
Respectfully this is a sample of one presented as a finding.
No trophies yet. Most accounts here never get one.
Independent testing plus vendor-level trend data. Community-funded, unaffiliated.
peptidemeter.comSeveral compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.
Reference